MagForce

MagForce (DB: MF6)

Currency in

Last close As at 06/12/2023

0.02

▲ 0.01 (100.00%)

Market capitalisation

—

Overview
Price performance
Financials
Research
Thematics

Edison Investment Research is terminating coverage on MagForce. Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.

Previously published reports can still be accessed via our website.

Latest Insights

Healthcare |
QuickView

10.11.21

MagForce — Primed to execute on its growth strategy

Healthcare |
Update

10.11.21

MagForce — Primed to execute on its growth strategy

Healthcare |
Update

14.07.21

MagForce — Time to capitalise on growth potential

Healthcare |
Update

11.02.21

MagForce — NanoTherm on track for US approval in 2021

Visit Website

Balance Sheet

Forecast net debt (€m)

N/A

Forecast gearing ratio (%)

N/A

Share Price Performance

Price Performance
%	1M	3M	12M
Actual	(73.9)	(99.0)	(99.5)
Relative	(75.2)	(99.0)	(99.4)
52 week high/low	€3.6/€0.0

Financials

MagForce is a German med-tech firm with a CE-mark approved nanotechnology cancer treatment. This consists of NanoTherm (iron nanoparticles), Nanoplan (software) and NanoActivator (a device that produces a powerful magnetic field to heat the nanoparticles, which destroys or sensitises tumour cells to therapy).

Y/E Dec	Revenue (€m)	EBITDA (€m)	PBT (€m)	EPS (c)	P/E (x)	P/CF (x)
2020A	0.6	19.3	(9.7)	(0.35)	N/A	N/A
2021A	0.4	(6.1)	(8.9)	(0.30)	N/A	N/A
2022E	N/A	N/A	N/A	N/A	N/A	N/A
2023E	N/A	N/A	N/A	N/A	N/A	N/A

Research

Update

Healthcare

13.07.20

MagForce — Key inflection points on the horizon

Update

Healthcare

29.04.20

MagForce — FDA approves streamlined trial protocol

Healthcare

Outlook

20.07.20

MagForce — Striding towards major inflection points

edison tv

Healthcare

09.12.19

Executive interview – Magforce at EKF 2019

Update

Healthcare

11.11.19

MagForce — The land of opportunity awaits NanoTherm

Update

Healthcare

07.11.19

MagForce — The land of opportunity awaits NanoTherm

Flash note

Healthcare

28.08.19

MagForce — US prostate cancer study progresses

Outlook

Healthcare

09.07.19

MagForce — Transitioning towards sustainable profitability

Update

Healthcare

03.07.19

MagForce — Revenue growth is needed from EU roll-out

Update

Healthcare

21.11.18

MagForce — 2019 a pivotal year

Update

Healthcare

07.11.18

MagForce — 2019 a pivotal year

Update

Healthcare

04.07.18

MagForce — NanoTherm US prostate cancer trial initiates

Update

Healthcare

18.05.18

MagForce — NO SUBTITLE

Update

Healthcare

17.05.18

MagForce — 2017 lays foundation for 2018 progress

Update

Healthcare

23.02.18

MagForce — US NanoTherm IDE approval a major milestone

Update

Healthcare

06.10.17

MagForce — H117: EIB funding to accelerate rollout

Update

Healthcare

13.07.17

MagForce — Update

Update

Healthcare

13.07.17

MagForce — FY16: Slow NanoTherm uptake affects top line

Initiation

Healthcare

17.05.17

MagForce — Steady progress

Outlook

Healthcare

15.05.17

MagForce — Steady progress

thematic

Healthcare

20.11.23

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

thematic

Healthcare

13.11.23

VolitionRx – Decoding the DNA of cancer

thematic

TMT

07.11.23

MediaWatch – November 2023: Still waiting…

thematic

Consumer

30.10.23

ConsumerWatch – October 2023

thematic

Metals & Mining

27.09.23

Shades of the 1970s

thematic

Industrials

04.09.23

The long and winding road

thematic

TMT

28.07.23

MediaWatch – July 2023

thematic

Consumer

26.07.23

ConsumerWatch – July 2023

thematic

Healthcare

13.06.23

ASCO 2023 key takeaways

thematic

Financials

09.05.23

IFRS 17: Impact on life assurance companies

thematic

TMT

25.04.23

MediaWatch – April 2023

thematic

Consumer

21.04.23

ConsumerWatch – April 2023

thematic

Industrials

13.04.23

Quantum computing: A booming industry

thematic

Metals & Mining

28.03.23

Critical minerals: The investment vacuum

thematic

Financials

17.03.23

Crypto, are you dead yet?

thematic

Industrials

27.02.23

UK housebuilders

thematic

Investment Companies

13.02.23

European equities

thematic

Investment Companies

08.02.23

Listed Private Equity

thematic

Metals & Mining

01.02.23

Lithium’s adolescence

Concept of energy storage unit consisting of multiple conected containers with batteries. 3d rednering.

thematic

Industrials

01.02.23

Battery energy storage

Digital Marketing and Internet Media Technology Platform

thematic

TMT

31.01.23

MediaWatch – January 2023

thematic

Investment Companies

27.01.23

Vietnamese equities: Due a comeback?

thematic

Healthcare

26.01.23

Machine learning in drug development

thematic

Consumer

23.01.23

ConsumerWatch – January 2023

thematic

Healthcare

06.01.23

Outlook for 2023: Biotechs remain central to novel drug development

thematic

Healthcare

04.01.23

Oncology ABCs (part four): Blood cancers (AML) – notable innovations

thematic

Healthcare

20.12.22

Cell and gene therapies

thematic

30.11.22

Investment companies: Latin America is worthy of consideration

thematic

Healthcare

28.11.22

Drug delivery platforms

thematic

Real Estate

11.11.22

South African industrial property fundamentals are strong

thematic

Metals & Mining

08.11.22

Lepidico: Offer closes, oversubscribed

thematic

Healthcare

07.11.22

Oncology ABCs (part three) – thinking outside the box in women’s cancer

thematic

03.11.22

UK motor P&C insurers series

thematic

Healthcare

01.11.22

Neuroscience comeback

thematic

Real Estate

24.10.22

South African retail property funds remain resilient

thematic

Consumer

13.10.22

ConsumerWatch – October 2022

thematic

Consumer

05.10.22

IPO apocalypse

thematic

Healthcare

03.10.22

Oncology ABCs (part two) – vaccines: niche no longer

thematic

Consumer

03.10.22

Food tech – At the forefront of food innovation

thematic

TMT

10.08.22

ESG, moving beyond the box tick

thematic

Consumer

18.07.22

ConsumerWatch – July 2022

thematic

Healthcare

01.07.22

Oncology ABCs (part one) – a small-cap biopharma prospectus series

thematic

Industrials

22.06.22

A new paradigm for space

thematic

30.05.22

Geopolitical conflict to drive renewables surge

thematic

Industrials

25.05.22

The emergence of mega-constellations

thematic

Industrials

23.05.22

Internet in the sky

thematic

12.05.22

Global markets: Valuation ‘normalisation’ continues

thematic

Financials

11.05.22

Revisiting IPOs in London

thematic

TMT

11.05.22

Direct tech investors

thematic

Investment Companies

10.05.22

The case for US capital markets

thematic

Industrials

10.05.22

Truth creates light

thematic

Industrials

09.05.22

All-seeing eye in the sky

thematic

Metals & Mining

27.04.22

Five (more) things every investor should know about lithium and Lepidico

thematic

Healthcare

26.04.22

24.03.22

Circular economy business models

thematic

Metals & Mining

21.03.22

04.02.22

Moving from a vegan January to a sustainable one

thematic

Industrials

02.02.22

BayWa – Focus on sustainability

thematic

19.01.22

Global perspectives: Earnings momentum still positive

thematic

Consumer

10.01.22

Cultivated meat – Engineering the growth of alternative meats

thematic

Metals & Mining

13.12.21

10.11.21

Artificial intelligence in drug discovery

thematic

Industrials

01.11.21

29.09.21

09.09.21

06.09.21

23.08.21

28.07.21

Finding the sea of green – The opportunity and options for shipping green H2

thematic

Healthcare

27.07.21

18.05.21

The circular economy

thematic

29.04.21

Equity strategy and market outlook – April 2021

thematic

Energy & Resources

28.04.21

Decarbonisation

thematic

Industrials

20.04.21

17.03.21

01.02.21

Confidence renewed as new COVID-19 vaccines demonstrate protection against emergent strains and efficacy with a single-dose regimen

thematic

28.01.21

07.12.20

29.10.20

16.08.20

24.06.20

08.04.20

27.02.20

12.12.19

30.10.19

Edison Exhibits- antibiotic development

thematic

24.10.19

Past the peak of political risk?

thematic

Industrials

17.10.19

Water – The real liquidity crisis

thematic

17.10.19

Illuminator – October Update

thematic

Industrials

16.10.19

14.08.19

Illuminator: August Update

thematic

14.08.19

Staying focused on the facts – the risks remain in place

thematic

Investment Companies

07.08.19

Post Woodford- A spotlight on smaller company liquidity

thematic

TMT

05.08.19

European video games

thematic

25.07.19

Equity strategy and market outlook – July 2019

thematic

Healthcare

17.07.19

10.07.19

Diversification and scale for online success

thematic

Financials

03.07.19

26.06.19

18.06.19

The A-B-T of biosimilars- Explaining contemporary life science issues

thematic

Healthcare

10.06.19

Cannabinoid Therapies- The coming retail wave

thematic

06.06.19

Could the US Fed be enabling a continuation of the trade war?

thematic

Investment Companies

05.06.19

22.05.19

Cannabinoid Therapies- Therapeutics turning a corner

thematic

20.05.19

Shifting trade politics should not be ignored

thematic

Metals & Mining

16.05.19

Alliance Mineral Assets secures strategic investment from Galaxy and Jiangxi

thematic

Financials

14.05.19

Time value of money

thematic

TMT

08.05.19

24.04.19

Piedmont Lithium increases its mineral resource estimate by 21%

thematic

18.04.19

Equity strategy and market outlook – April 2019

thematic

Financials

15.04.19

Cash flow

thematic

09.04.19

Stronger survey data quashes recession fears for now

thematic

Healthcare

08.04.19

Trial outcomes and value – Explaining contemporary clinical trial issues

thematic

08.04.19

Industrial Automation

thematic

Energy & Resources

03.04.19

26.03.19

Types of investment trusts

thematic

21.03.19

Brexit: EU can do it if you really want…

thematic

Energy & Resources

20.03.19

Orinduik resource upgrade for Eco Atlantic offshore Guyana

thematic

14.03.19

Brexit: PM May’s deal may finally be in sight

thematic

Energy & Resources

13.03.19

No moveable hydrocarbons in Alaskan Winx-1 well

thematic

Energy & Resources

12.03.19

04.03.19

26.02.19

UK video games – Heterogeneous not homogeneous

thematic

14.02.19

Market outlook: balanced but still biased to upside

thematic

Financials

08.02.19

Enterprise versus equity valuation

thematic

Healthcare

29.01.19

The diagnostics sector

thematic

28.01.19

ECB fiddles as eurozone turns

thematic

Metals & Mining

22.01.19

Gold stars and black holes

thematic

Financials

15.01.19

Deutsche Börse’s Scale

thematic

Financials

08.01.19

20.11.18

25.09.18

04.09.18

Tullow spuds Cormorant well offshore Namibia

thematic

Energy & Resources

20.08.18

Southern gas corridor to the EU nears agreement

thematic

13.08.18

Turkey:When risks collide

thematic

Energy & Resources

01.08.18

28.03.18

07.02.18

13.12.17

Kosmos exploration hiccups

thematic

Energy & Resources

06.12.17

Positive news from Genel’s Taq Taq

thematic

24.11.17

Economic surprise accelerating

thematic

Energy & Resources

20.11.17

Ludicrous growth of the EV

thematic

Energy & Resources

07.11.17

Tullow’s Araku result completes our 2017 wells to watch list

thematic

Energy & Resources

16.10.17

Fancy a Ferrari or an EV?

thematic

Energy & Resources

10.10.17

Verbier delivers after sidetrack

thematic

09.10.17

Economic data surprising to the upside in Q3

thematic

Energy & Resources

03.10.17

Revealing Big Oil hurdle rates

thematic

28.09.17

Earnings momentum – 2017 forecasts drifting slowly lower

thematic

Energy & Resources

26.09.17

Fatala well latest disappointment offshore West Africa

thematic

Energy & Resources

18.09.17

Partridge and Verbier fail to find oil

thematic

12.09.17

Interesting times for central bankers

thematic

Energy & Resources

17.08.17

08.08.17

Kosmos searching for more investors

thematic

Energy & Resources

26.07.17

21.06.17

ASCO 2017

thematic

21.06.17

Equity risks are rising: economic surprises turning lower

thematic

Energy & Resources

20.06.17

07.06.17

Porcupine Basin attracts Total

thematic

Energy & Resources

26.05.17

02.05.17

Cairn/FAR return to deepwater FAN in Senegal

thematic

24.04.17

French Election: Is populism already passé?

thematic

Energy & Resources

12.04.17

01.03.17

What a difference a year makes

thematic

TMT

24.02.17

15.02.17

Filicudi discovery – positive start to 2017 Barents exploration

thematic

Energy & Resources

10.02.17

Tullow dipping a toe back into exploration

thematic

TMT

08.02.17

Mobile ecosystems

thematic

Energy & Resources

06.02.17

Diversified Gas and Oil – quick thoughts

thematic

03.02.17

Implicit forward guidance on asset prices?

thematic

Energy & Resources

27.01.17

24.11.16

Fortuna LNG deal underlines the structurally higher costs of capital seen by E&Ps

thematic

Energy & Resources

24.11.16

Equities

Equities by Sector

Sectors

Investment Strategy

Latest

Equity Strategy and Market outlook – October 2023

Equity strategy and market outlook – September 2023

Equity strategy and market outlook – August 2023

Thematics

Latest

Deutsches Eigenkapitalforum (EKF) 2023 consumer and media

Deutsches Eigenkapitalforum (EKF) 2023 technology

Deutsches Eigenkapitalforum (EKF) 2023 financials and investment companies

About Edison

About Edison

Careers

MagForce (DB: MF6)

Latest Insights

MagForce — Primed to execute on its growth strategy

MagForce — Primed to execute on its growth strategy

MagForce — Time to capitalise on growth potential

MagForce — NanoTherm on track for US approval in 2021

Balance Sheet

Share Price Performance

Financials

Research

MagForce — Key inflection points on the horizon

MagForce — FDA approves streamlined trial protocol

MagForce — Striding towards major inflection points

Executive interview – Magforce at EKF 2019

MagForce — The land of opportunity awaits NanoTherm

MagForce — The land of opportunity awaits NanoTherm

MagForce — US prostate cancer study progresses

MagForce — Transitioning towards sustainable profitability

MagForce — Revenue growth is needed from EU roll-out

MagForce — 2019 a pivotal year

MagForce — 2019 a pivotal year

MagForce — NanoTherm US prostate cancer trial initiates

MagForce — NO SUBTITLE

MagForce — 2017 lays foundation for 2018 progress

MagForce — US NanoTherm IDE approval a major milestone

MagForce — H117: EIB funding to accelerate rollout

MagForce — Update

MagForce — FY16: Slow NanoTherm uptake affects top line

MagForce — Steady progress

MagForce — Steady progress

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

VolitionRx – Decoding the DNA of cancer

MediaWatch – November 2023: Still waiting…

ConsumerWatch – October 2023

Shades of the 1970s

The long and winding road

MediaWatch – July 2023

ConsumerWatch – July 2023

ASCO 2023 key takeaways

IFRS 17: Impact on life assurance companies

MediaWatch – April 2023

ConsumerWatch – April 2023

Quantum computing: A booming industry

Critical minerals: The investment vacuum

Crypto, are you dead yet?

UK housebuilders

European equities

Listed Private Equity

Lithium’s adolescence

Battery energy storage

MediaWatch – January 2023

Vietnamese equities: Due a comeback?

Machine learning in drug development

ConsumerWatch – January 2023

Outlook for 2023: Biotechs remain central to novel drug development

Oncology ABCs (part four): Blood cancers (AML) – notable innovations

Cell and gene therapies

Investment companies: Latin America is worthy of consideration

Drug delivery platforms

South African industrial property fundamentals are strong

Lepidico: Offer closes, oversubscribed

Oncology ABCs (part three) – thinking outside the box in women’s cancer

UK motor P&C insurers series

Neuroscience comeback